Consecutive Monitoring of Interleukin-6 Is Needed for COVID-19 Patients

Aziz M, Fatima R, Assaly R (2020) Elevated interleukin-6 and severe COVID-19: a meta-analysis. J Med Virol 92:2283–2285

CAS  Article  Google Scholar 

Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, Ma K, Xu D, Yu H, Wang H, Wang T, Guo W, Chen J, Ding C, Zhang X, Huang J, Han M, Li S, Luo X, Zhao J, Ning Q (2020a) Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ-Brit Med J 368:m1295

Google Scholar 

Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y, Men D, Huang Q, Liu Y, Yang B, Ding J, Li F (2020b) Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) Is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019. Clin Infect Dis 71:1937–1942

CAS  Article  Google Scholar 

Fu YJ, Cheng YX, Wu YT (2020) Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools. Virol Sin 35:266–271

CAS  Article  Google Scholar 

Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, Haagmans BL, Lauber C, Leontovich AM, Neuman BW, Penzar D, Perlman S, Poon LLM, Samborskiy DV, Sidorov IA, Sola I, Ziebuhr J, Coronaviridae Study G (2020) The species severe acute respiratory syndrome-related coronavirus classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 5:536–544

Article  Google Scholar 

Grifoni E, Valoriani A, Cei F, Lamanna R, Gelli AMG, Ciambotti B, Vannucchi V, Moroni F, Pelagatti L, Tarquini R, Landini G, Vanni S, Masotti L (2020) Interleukin-6 as prognosticator in patients with COVID-19. J Infect 81:466–467

Article  Google Scholar 

Guan WY, Lan WD, Zhang J, Zhao S, Ou JX, Wu XW, Yan YQ, Wu JG, Zhang QW (2020) COVID-19: antiviral agents, antibody development and traditional chinese medicine. Virol Sin 35:685–698

CAS  Article  Google Scholar 

Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, Zhang P, Liu X, Gao G, Liu F, Jiang Y, Cheng X, Zhu C, Xia Y (2020) Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect 9:1123–1130

CAS  Article  Google Scholar 

Herold T, Jurinovic V, Arnreich C, Lipworth BJ, Hellmuth JC, von Bergwelt-Baildon M, Klein M, Weinberger T (2020) Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. J Allergy Clin Immunol 146:128–136

CAS  Article  Google Scholar 

Huang CL, Wang YM, Li X, Ren LL, Gu XY, Kang L, Guo L, Liu M, Zhou X, Luo JF, Huang ZH, Tu SJ, Zhao Y, Chen L, Xu DC, Li YP, Li CH, Peng L, Li Y, Xie WX, Cui D, Shang LH, Fan GH, Xu JY, Wang G, Wang Y, Zhong JC, Wang C, Wang JW, Zhang DY, Cao B (2021) 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 397:220–232

CAS  Article  Google Scholar 

Laguna-Goya R, Utrero-Rico A, Talayero P, Lasa-Lazaro M, Ramirez-Fernandez A, Naranjo L, Segura-Tudela A, Cabrera-Marante O, Rodriguez de Frias E, Garcia-Garcia R, Fernandez-Ruiz M, Maria Aguado J, Martinez-Lopez J, Ana Lopez E, Catalan M, Serrano A, Paz-Artal E (2020) IL-6-based mortality risk model for hospitalized patients with COVID-19. J Allergy Clin Immunol 146:799–807

CAS  Article  Google Scholar 

Li TB, Huang T, Guo C, Wang AL, Shi XL, Mo XF, Lu QQ, Sun J, Hui TT, Tian G, Wang LY, Yang JL (2021) Genomic variation, origin tracing, and vaccine development of SARS-CoV-2L: a systematic review. The Innov 2:100116

Google Scholar 

Liu F, Li L, Xu M, Wu J, Luo D, Zhu Y, Li B, Song X, Zhou X (2020a) Prognostic value of interleukin-6, C -reactive protein, patients with COVID-19 and procalcitonin in patients with COVID-19. J Clin Virol 127:104370

CAS  Article  Google Scholar 

Liu T, Zhang J, Yang Y, Ma H, Li Z, Zhang J, Cheng J, Zhang X, Zhao Y, Xia Z, Zhang L, Wu G, Yi J (2020b) The role of interleukin-6 in monitoring severe case of coronavirus disease 2019. EMBO Mol Med 12:e12421

CAS  Article  Google Scholar 

Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, Speciality HLHA (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395:1033–1034

CAS  Article  Google Scholar 

Moore JB, June CH (2020) Cytokine release syndrome in severe COVID-19. Science 368:473–474

CAS  Article  Google Scholar 

Ruan Q, Yang K, Wang W, Jiang L, Song J (2020) Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 46:846–848

CAS  Article  Google Scholar 

Ulhaq ZS, Soraya GV (2020) Interleukin-6 as a potential biomarker of COVID-19 progression. Med Mal Infect 50:382–383

Article  Google Scholar 

Velazquez-Salinas L, Verdugo-Rodriguez A, Rodriguez LL, Borca MV (2019) The role of interleukin 6 during viral infections. Front Microbiol 10:1057

Article  Google Scholar 

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395:1054–1062

CAS  Article  Google Scholar 

Zhu Z, Cai T, Fan L, Lou K, Hua X, Huang Z, Gao G (2020) Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019. Int J Infect Dis 95:332–339

CAS  Article  Google Scholar 

留言 (0)

沒有登入
gif